For US Healthcare Professionals
Difficulty getting around
due to poor balance or
freezing of gait4,5
Not wanting to go to
restaurants due to difficulty
handling
utensils3,4
Avoiding being seen in
public due to tremor or
bradykinesia2
Fearing falling in public
due to postural instability
or poor
balance4-6
*Based on statistically significant associations with OFF periods shown in a cross-sectional survey of 722 patients with Parkinson’s disease (PD).
†Based on a survey of 47 patients with PD and matched carepartners.
INBRIJA is indicated for intermittent treatment of OFF episodes in patients with Parkinson’s disease (PD) treated with carbidopa/levodopa.
Please see the Full Prescribing Information.
Intermittent treatment of OFF episodes in patients with PD treated with CD/LD.
Contraindicated in patients taking or who have recently taken (within 2 weeks) nonselective monoamine oxidase (MAO) inhibitors (e.g., phenelzine and tranylcypromine) due to hypertension risk. Discontinue use of nonselective MAO inhibitors at least 2 weeks prior to initiating INBRIJA.